An introduction to the Marburg virus vaccine consortium, MARVAC

• Robert W. Cross ,

  * E-mail: rwcross@utmb.edu (RWC); marzia@niaid.nih.gov (AM)

  Affiliation Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America

  ⨯
• Ira M. Longini,

  Affiliation Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Stephan Becker,

  Affiliation Institute for Virology, Philipps-Universität Marburg, Marburg, Germany

  ⨯
• Karin Bok,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• David Boucher,

  Affiliation U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America

  ⨯
• Miles W. Carroll,

  Affiliation Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom

  ⨯
• Janet V. Díaz,

  Affiliation World Health Organization, Geneva, Switzerland

  ⨯
• William E. Dowling,

  Affiliation Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America

  ⨯
• Ruxandra Draghia-Akli,

  Affiliation Johnson & Johnson—Global Public Health Research and Development, Spring House, Pennsylvania, United States of America

  ⨯
• James T. Duworko,

  Affiliation Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia

  ⨯
• John M. Dye,

  Affiliation Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America

  ⨯
• Michael A. Egan,

  Affiliation Auro Vaccines, Pearl River, New York, United States of America

  ⨯
• Patricia Fast,

  Affiliation IAVI, New York, New York, United States of America

  ⨯
• Amy Finan,

  Affiliation Sabin vaccine Institute, Washington, DC, United States of America

  ⨯
• Courtney Finch,

  Affiliation Sabin vaccine Institute, Washington, DC, United States of America

  ⨯
• Thomas R. Fleming,

  Affiliation University of Washington, Seattle, Washington, United States of America

  ⨯
• Joan Fusco,

  Affiliation Public Health Vaccines, Cambridge, Massachusetts, United States of America

  ⨯
• Thomas W. Geisbert,

  Affiliation Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America

  ⨯
• Anthony Griffiths,

  Affiliation National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America

  ⨯
• Stephan Günther,

  Affiliation Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

  ⨯
• Lisa E. Hensley,

  Affiliation Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America

  ⨯
• Anna Honko,

  Affiliation National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America

  ⨯
• Ruth Hunegnaw,

  Affiliation Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jocelyn Jakubik,

  Affiliation Sabin vaccine Institute, Washington, DC, United States of America

  ⨯
• Julie Ledgerwood,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Kerstin Luhn,

  Affiliation Janssen Vaccines & Prevention, Leiden, the Netherlands

  ⨯
• Demetrius Matassov,

  Affiliation Auro Vaccines, Pearl River, New York, United States of America

  ⨯
• Jeffrey Meshulam,

  Affiliation Auro Vaccines, Pearl River, New York, United States of America

  ⨯
• Emily V. Nelson,

  Affiliation Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

  ⨯
• Christopher L. Parks,

  Affiliation IAVI, New York, New York, United States of America

  ⨯
• Roxana Rustomjee,

  Affiliation Sabin vaccine Institute, Washington, DC, United States of America

  ⨯
• David Safronetz,

  Affiliation Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Lauren M. Schwartz,

  Affiliation World Health Organization, Geneva, Switzerland

  ⨯
• Dean Smith,

  Affiliation Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada

  ⨯
• Paul Smock,

  Affiliation Sabin vaccine Institute, Washington, DC, United States of America

  ⨯
• Ydrissa Sow,

  Affiliation Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Christina F. Spiropoulou,

  Affiliation Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  ⨯
• Nancy J. Sullivan,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Kelly L. Warfield,

  Affiliation Emergent BioSolutions, Gaithersburg, Maryland, United States of America

  ⨯
• Daniel Wolfe,

  Affiliation Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada

  ⨯
• Courtney Woolsey,

  Affiliation Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America

  ⨯
• Roland Zahn,

  Affiliation Janssen Vaccines & Prevention, Leiden, the Netherlands

  ⨯
• Ana María Henao-Restrepo,

  Affiliation World Health Organization, Geneva, Switzerland

  ⨯
• César Muñoz-Fontela,

  Affiliation Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

  ⨯
•  [ ... ],
• Andrea Marzi

  * E-mail: rwcross@utmb.edu (RWC); marzia@niaid.nih.gov (AM)

  Affiliation Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America

  https://orcid.org/0000-0003-0186-9587

  ⨯
• [ view all ]
• [ view less ]